Hospital Admissions in Children Aged 3 Months to 5 Years Presenting With Fever to the Emergency Department
Launched by IMPERIAL COLLEGE HEALTHCARE NHS TRUST · Sep 7, 2010
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
A significant number of children 0 to 5 years of age are seen in paediatric Accident \& Emergency departments (A\&E) with feverish illness. Most of these patients could safely be managed in a primary care setting, particularly with guidelines in place on how to optimally assess these children. Some patients, however, will require admission, either because of a potentially serious underlying disease or because of other factors, for example parental concern or difficulties in communication because of language barriers. An increase in the number of children attending A\&E departments with feve...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Child aged 3months to 5years
- • Temperature above or equal to 38°C measured by any method or reported hot by parents
- Exclusion Criteria:
- • none
About Imperial College Healthcare Nhs Trust
Imperial College Healthcare NHS Trust is a leading healthcare provider in London, renowned for its commitment to delivering high-quality patient care and advancing medical research. As an integral part of the NHS, the Trust encompasses a range of specialized services and facilities, including multiple hospitals and outpatient centers, where it fosters a collaborative environment for clinical trials. With a focus on innovation and excellence, Imperial College Healthcare NHS Trust supports a diverse portfolio of clinical research initiatives aimed at translating scientific discoveries into effective treatments and improving health outcomes for patients. Its partnership with Imperial College London enhances its capabilities in cutting-edge research, making it a pivotal institution in the landscape of healthcare and clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, , Switzerland
London, , United Kingdom
Patients applied
Trial Officials
Hermione Lyall, MD
Principal Investigator
Imperial College Healthcare NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials